Vycor Medical (VYCO) Long-Term Deferred Tax (2014 - 2025)

Vycor Medical (VYCO) has 9 years of Long-Term Deferred Tax data on file, last reported at $4.2 million in Q4 2025.

• On a quarterly basis, Long-Term Deferred Tax rose 8420.41% year-over-year to $4.2 million in Q4 2025; TTM through Dec 2025 was $4.2 million, a 8420.41% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 8420.41% from the prior year.
• Long-Term Deferred Tax for Q4 2025 stood at $4.2 million, up from $49000.0 in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for VYCO reached as high as $4.2 million in Q4 2022 and fell as low as $49000.0 in Q4 2024.
• Historically, Long-Term Deferred Tax has averaged $2.6 million across 5 years, with a median of $4.0 million in 2021.
• Across the five-year window, Long-Term Deferred Tax sank 89.9% in 2024 and soared 8420.41% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $4.0 million in 2021, then advanced by 4.32% to $4.2 million in 2022, then plunged by 88.38% to $485000.0 in 2023, then sank by 89.9% to $49000.0 in 2024, then surged by 8420.41% to $4.2 million in 2025.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $4.2 million in Q4 2025, $49000.0 in Q4 2024, and $485000.0 in Q4 2023.